Using a continuous fluorescence-based enzyme assay, we have characterized the antibacterial agents tunicamycin and liposidomycin B as inhibitors of solubilized Escherichia coli phospho-N-acetylmuramyl- pentapeptide translocase. Tunicamycin exhibited reversible inhibition (K(i) = 0.55 ± 0.1 μM) which was noncompetitive with respect to the lipid acceptor substrate and competitive with respect to the fluorescent substrate analog, dansyl-UDPMurNAc-pentapeptide. Liposidomycin B exhibited slow-binding inhibition (K(i) = 80 ± 15 nM) which was competitive with respect to the lipid acceptor substrate and noncompetitive with respect to dansyl-UDPMurNAc- pentapeptide. These results provide insight into the molecular mechanisms of action of these two classes of nucleoside antibiotics.
CITATION STYLE
Brandish, P. E., Kimura, K. I., Inukai, M., Southgate, R., Lonsdale, J. T., & Bugg, T. D. H. (1996). Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: Inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrobial Agents and Chemotherapy, 40(7), 1640–1644. https://doi.org/10.1128/aac.40.7.1640
Mendeley helps you to discover research relevant for your work.